The POINT BIOPHARMA brand, founded in 2018 (United States), from 588 sister brands and 17479 competing brands. POINT BIOPHARMA is a brand of ELI LILLY AND COMPANY, listed on the stock exchange of New York. POINT BIOPHARMA is part of the Drug Manufacturers activity sector.

POINT BIOPHARMA is a brand of ELI LILLY AND COMPANY (LLY) Share price

Share price and profitability of the share ELI LILLY AND COMPANY (POINT BIOPHARMA)

Buy ELI LILLY AND COMPANY share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested $831.54

Portfolio valuation
ELI LILLY AND COMPANY (POINT BIOPHARMA) over 5 years* $6,144.25

Stock market history ELI LILLY AND COMPANY (POINT BIOPHARMA)

Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more